Evaluating Risankizumab’s Long-Term Effects in Psoriasis Using Optical Coherence Tomography
Abstract Introduction Psoriasis is a chronic inflammatory disease associated with multiple systemic comorbidities and reduced quality of life. Risankizumab, an interleukin (IL)-23 inhibitor, has demonstrated efficacy in achieving rapid and sustained skin clearance in moderate-to-severe psoriasis. Ho...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Adis, Springer Healthcare
2026-01-01
|
| Schriftenreihe: | Dermatology and Therapy |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1007/s13555-025-01637-2 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|